Call for Papers

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.
We'd appreciate your feedback on this new experience.Tell us what you think(opens in new tab/window)
Congratulations to JAAD
Congratulations to Dr. Grant-Kels on Clarence S. Livingood, MD Award and Lectureship
Case reports prompt CDC investigation of possible treatment-resistant dermatophytosis
Congratulations and Welcome to Dr. Julia Riley, JAAD Case Reports New Skin of Color Special Editor
JAAD Skin of Color Image Collection and Atlas
Digital Health in Dermatology
COVID-19 and the Skin
For the fourth year in a row JAAD(opens in new tab/window) holds the #1 Impact Factor in the Dermatology category with a 2022 IF of 13.8!
JAAD Deputy Editor Jane Grant-Kels, MD, FAAD, professor of dermatology, pathology, and pediatrics, and director of the Cutaneous Oncology Center and Melanoma Program at the University of Connecticut, delivered the Clarence S. Livingood, MD Award and Lectureship during the Plenary Session at the 2023 AAD Annual Meeting in New Orleans on March 19.
Speaking on the topic “Ethical Dilemmas Hiding in Plain Site(opens in new tab/window)”, Dr. Grant-Kels explored the importance of ethics and the nuanced boundaries of ethical behavior in the practice of dermatology.
To read more about the substance of this lecture, and other news from the 2023 AAD Annual Meeting, visit the DermWorld Meeting News Central website(opens in new tab/window).
Jane Grant-Kels
Responding to JAAD Case Reports articles indicating a growing problem, the United States Centers for Disease Control and Prevention (CDC) is investigating whether a pattern of treatment-resistant dermatophytosis is emerging.
The CDC asks dermatologists who see patients with tinea infections to complete its survey so it can assess the extent of this problem.
Gu, David et al reported what they believed to be the first U.S. case of treatment-resistant dermatophytosis in a 2020 JAAD Case Reports article(opens in new tab/window). A response in 2022(opens in new tab/window) suggested a second case had been identified. The literature indicates that treatment resistance has been seen in India and possibly elsewhere.
Dr. Julia Riley is an Assistant Professor of Dermatology at Feinberg School of Medicine. Dr. Riley completed her residency at Northwestern in 2020 before joining the faculty. At Northwestern, she serves as the Assistant Director of the Center for Ethnic Skin & Hair and the Director of the HS Clinic. She also serves as the Dermatology Clerkship Director and the Co-Chair of the Department of Dermatology’s Diversity and Inclusion Committee. Her clinical interests include Skin of Color, spanning from pigmentary disorders to hair disorders, as well as Hidradenitis Suppurativa. Her research interests include disparities in Hidradenitis Suppurativa as well as education of residents, medical students and other health care providers on the diagnosis and management of dermatologic conditions in patients of color. Additionally, Dr. Riley is pursuing a master’s degree in health services and outcomes research.
Dr. Julia Riley
Recent studies have shown the disparities and subsequent effects in recognizing diseases in skin of color. They point out the lack of representation of images of skin of color in major textbooks and teaching sets and propose a proactive approach to photographing and publishing more images of diseases in patients with darker skin types.
View the entire Skin of Color collection of images and articles(opens in new tab/window)
Join JAADi Editor Dr. Jonathan Kantor as he discusses this important topic with an engaging team of experts
Missed our webinars on COVID-19 and the Skin?